文献速递生殖医学

ICMART 2013年全球辅助生殖技术报告

International Committee for Monitoring Assisted Reproductive Technologies (ICMART): world report on assisted reproductive technologies, 2013.
PubMed 文献 · Fertil Steril · 2021-04-27

该报告为ICMART对2013年全球ART使用、有效性与安全性的回顾性横断面调查,覆盖75个国家2639家诊所、共1,858,500个周期,全球参与率73.6%。报告估计1,160,474次胚胎移植后出生超过344,317名婴儿,并汇总各国家、区域与全球层面的结局。

要点

  • 2013年全球ART周期1,858,500个,覆盖75国2639家诊所,参与率73.6%。
  • 新鲜IVF/ICSI每取卵周期活产率24.2%,冻胚移植周期22.8%。
  • 冻胚移植单胚胎移植占57.6%,双胎率10.8%、三胎率0.4%。

核心结论

  • 2012至2013年间报告的ART周期数、有效性与安全性上升,部分与采用更好的未报告周期估算方法有关。
  • 本报告覆盖全球约三分之二的ART活动,仍需持续提高登记数据报告的质量与一致性。

研究设计与样本

  • 回顾性、横断面调查,分析2013年全球ART的使用、有效性与安全性。
  • 覆盖75个国家、2,639家ART诊所,共1,858,500个ART周期,全球参与率73.6%。
  • 基于ICMART开发的方法汇总与分析各国数据。

主要发现

  • 2013年共1,858,500个ART周期,报告与估算数据提示完成1,160,474次胚胎移植,出生超过344,317名婴儿。
  • 2012至2013年,报告的取卵周期数与冻胚移植周期数分别增加3%与16.4%。
  • 接受非供卵ART的40岁以上女性比例由2012年的25.2%升至2013年的26.3%。
  • 新鲜非供卵周期单胚胎移植比例由2012年33.7%升至2013年36.5%,平均移植胚胎数1.81个,双胎率17.9%、三胎率0.7%。
  • 冻胚移植周期单胚胎移植57.6%,平均移植1.49个胚胎,双胎率10.8%、三胎率0.4%,每取卵周期累积活产率30.4%。

关键数值与推荐

  • 新鲜取卵周期与冻胚移植周期的IVF/ICSI合并活产率分别为24.2%与22.8%。
  • 新鲜IVF/ICSI后围产期死亡率每1,000例出生为22.2,冻胚移植后为16.8。
  • 以非供卵取卵周期为分母,ICSI占比与2012年结果相近。

临床怎么用

  • 可作为生殖中心了解2013年全球ART利用率、有效性与安全性的参考基线。
  • 提示单胚胎移植比例上升、多胎率与围产期死亡率仍是关注重点。
  • 数据存在国家间差异,解读各国指标时需考虑报告质量与完整性。

局限性

  • 数据依赖各国提交资料的质量与完整性。
  • 报告仅覆盖全球约三分之二的ART活动。
  • 各指标存在较大国家间差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the utilization, effectiveness, and safety of practices in assisted reproductive technology (ART) globally in 2013 and assess global trends over time. DESIGN: Retrospective, cross-sectional survey on the utilization, effectiveness, and safety of ART procedures performed globally during 2013. SETTING: Seventy-five countries and 2,639 ART clinics. PATIENT(S): Women and men undergoing ART procedures. INTERVENTION(S): All ART. MAIN OUTCOME MEASURE(S): The ART cycles and outcomes on country-by-country, regional, and global levels. Aggregate country data were processed and analyzed based on methods developed by the International Committee for Monitoring Assisted Reproductive Technology (ICMART). RESULT(S): A total of 1,858,500 ART cycles were conducted for the treatment year 2013 across 2,639 clinics in 75 participating countries with a global participation rate of 73.6%. Reported and estimated data suggest 1,160,474 embryo transfers (ETs) were performed resulting in >344,317 babies. From 2012 to 2013, the number of reported aspiration and frozen ET cycles increased by 3% and 16.4%, respectively. The proportion of women aged >40 years undergoing nondonor ART increased from 25.2% in 2012 to 26.3% in 2013. As a percentage of nondonor aspiration cycles, intracytoplasmic sperm injection (ICSI) was similar to results for 2012. The in vitro fertilization (IVF)/ICSI combined delivery rates per fresh aspiration and frozen ET cycles were 24.2% and 22.8%, respectively. In fresh nondonor cycles, single ET increased from 33.7% in 2012 to 36.5% in 2013, whereas the average number of transferred embryos was 1.81-again with wide country variation. The rate of twin deliveries after fresh nondonor transfers was 17.9%; the triplet rate was 0.7%. In frozen ET cycles performed in 2013, single ET was used in 57.6%, with an average of 1.49 embryos transferred and twin and triplet rates of 10.8% and 0.4%, respectively. The cumulative delivery rate per aspiration was 30.4%, similar to that in 2012. Perinatal mortality rate per 1,000 births was 22.2% after fresh IVF/ICSI and 16.8% after frozen ET. The data presented depended on the quality and completeness of the data submitted by individual countries. This report covers approximately two-thirds of world ART activity. Continued efforts to improve the quality and consistency of reporting ART data by registries are still needed. CONCLUSION(S): Reported ART cycles, effectiveness, and safety increased between 2012 and 2013 with adoption of a better method for estimating unreported cycles.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Banker M, Dyer S, Chambers GM, et al. International Committee for Monitoring Assisted Reproductive Technologies (ICMART): world report on assisted reproductive technologies, 2013. Fertil Steril. 2021. PMID: 33926722. doi:10.1016/j.fertnstert.2021.03.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。